Side-by-side comparison

Retatrutide

Triple-Action Metabolic CompoundSafety 7/10

GLP-1 / metabolic research

vs

Cagrilintide

Metabolic Research PeptideSafety 7/10

GLP-1 / appetite research

Retatrutide
Cagrilintide
Cheapest price
$25.20 /10mg
$55.99 /10mg
Vendors stocking
24
17
Safety rating
7/10
7/10
Mol. weight
4,731 g/mol
4,409 g/mol
Administration
Subcutaneous injection
Subcutaneous injection

Price Comparison — 2026

Retatrutide

VendorPrice
Alpha Peptides$25.20 /10mgBuy →
Red River Peptides$26.77 /10mgBuy →
Puratek Peptides$26.99 /10mgBuy →
Peptyx Labs$33.33 /10mgBuy →
NeuroLabs$41.63 /10mgBuy →
Hydro Research$43.75 /10mgBuy →

Cagrilintide

VendorPrice
Amino Club$55.99 /10mgBuy →
Puratek Peptides$65.66 /10mgBuy →
Midwest Peptide$80.99 /10mgBuy →
Optimum Formula$89.98 /10mgBuy →
SomaChems$95.98 /10mgBuy →
LA Peptides$99.99 /10mgBuy →

Vendors Carrying Both

14 vendors stock both Retatrutide and Cagrilintide — convenient if you want to bundle an order.

Puratek PeptidesRetatrutide: $26.99Cagrilintide: $65.66Visit →
Midwest PeptideRetatrutide: $63.00Cagrilintide: $80.99Visit →
Optimum FormulaRetatrutide: $90.00Cagrilintide: $89.98Visit →
LA PeptidesRetatrutide: $76.66Cagrilintide: $99.99Visit →
Pantheon PeptidesRetatrutide: $87.48Cagrilintide: $100.44Visit →
Onyx ResearchRetatrutide: $99.00Cagrilintide: $110.00Visit →
Hydro ResearchRetatrutide: $43.75Cagrilintide: $110.00Visit →
PeptiraRetatrutide: $59.67Cagrilintide: $119.00Visit →
Licensed PeptidesRetatrutide: $51.66Cagrilintide: $122.99Visit →
NeuroLabsRetatrutide: $41.63Cagrilintide: $126.00Visit →
Evolve PeptidesRetatrutide: $84.97Cagrilintide: $127.50Visit →
Modern AminosRetatrutide: $82.28Cagrilintide: $134.00Visit →
Novatherix LaboratoriesRetatrutide: $54.00Cagrilintide: $179.98Visit →
PeptuviaRetatrutide: $154.00Cagrilintide: $246.00Visit →

Safety Notes

Retatrutide

FDA: Not FDA-approved (Phase III)

Phase II showed strong efficacy/tolerability; GI side effects; novel mechanism; promising safety data

Cagrilintide

FDA: Not FDA-approved (Phase III)

Phase III trials show good tolerability; GI side effects; injection site reactions

Failed to fetch